Vertex Pharmaceuticals | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
AbbVie USD 700M 90M 2025-03
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Amgen USD 694M 29M 2025-06
Arrowhead Research USD 24.38M 2.74M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Gilead Sciences USD 254M 6M 2025-06
Incyte USD 594K 66K 2025-06
Insmed USD 21.24M 1.5M 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
J&J USD 128M 9M 2025-03
Merck USD 305M 8M 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
Pfizer USD 654M 0 2025-06
PTC Therapeutics USD 30.36M 4.03M 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 148M 65M 2025-06
Sarepta Therapeutics USD 5.23M 725K 2025-06
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
United Therapeutics USD 7.3M 1.2M 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06


Vertex Pharmaceuticals Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.